{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:20:36Z","timestamp":1783693236420,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Key Project of Research and Development Plan","award":["2017YFA0104101"],"award-info":[{"award-number":["2017YFA0104101"]}]},{"name":"General Project of the National Natural Science Found","award":["81770973"],"award-info":[{"award-number":["81770973"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00417-019-04315-0","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T20:04:44Z","timestamp":1556913884000},"page":"1611-1619","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["OCT angiography-based monitoring of neovascular regression on fibrovascular membrane after preoperative intravitreal conbercept injection"],"prefix":"10.1007","volume":"257","author":[{"given":"Zizhong","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangdong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,3]]},"reference":[{"key":"4315_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376:124\u2013136. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(09)62124-3","journal-title":"Lancet"},{"key":"4315_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","volume":"118","author":"AP Adamis","year":"1994","unstructured":"Adamis AP, Miller JW, Bernal M-T, D'Amico DJ, Folkman J, Yeo T-K, Yeo K-T (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445\u2013450. \n                    https:\/\/doi.org\/10.1016\/S0002-9394(14)75794-0","journal-title":"Am J Ophthalmol"},{"key":"4315_CR3","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/S0140-6736(17)32426-1","volume":"390","author":"L Liu","year":"2017","unstructured":"Liu L, Tham YC, Cheng CY (2017) Intravitreal aflibercept for proliferative diabetic retinopathy. Lancet 390:2140\u20132141. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(17)32426-1","journal-title":"Lancet"},{"key":"4315_CR4","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/j.ophtha.2006.05.064","volume":"113","author":"RL Avery","year":"2006","unstructured":"Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ, Wendel R, Patel A (2006) Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113:1695\u20131705.e1696. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2006.05.064","journal-title":"Ophthalmology"},{"key":"4315_CR5","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/IAE.0000000000000900","volume":"36","author":"L Su","year":"2016","unstructured":"Su L, Ren X, Wei H, Zhao L, Zhang X, Liu J, Su C, Tan L, Li X (2016) Intravitreal conbercept (KH902) for surgical treatment of severe proliferative diabetic retinopathy. Retina 36:938\u2013943. \n                    https:\/\/doi.org\/10.1097\/iae.0000000000000900","journal-title":"Retina"},{"key":"4315_CR6","doi-asserted-by":"publisher","unstructured":"Smith JM, Steel DH (2015) Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy. Cochrane Database Syst Rev Cd008214. \n                    https:\/\/doi.org\/10.1002\/14651858.CD008214.pub3","DOI":"10.1002\/14651858.CD008214.pub3"},{"key":"4315_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ajo.2013.02.008","volume":"156","author":"ZH Zhang","year":"2013","unstructured":"Zhang ZH, Liu HY, Hernandez-Da Mota SE, Romano MR, Falavarjani KG, Ahmadieh H, Xu X, Liu K (2013) Vitrectomy with or without preoperative intravitreal bevacizumab for proliferative diabetic retinopathy: a meta-analysis of randomized controlled trials. Am J Ophthalmol 156:106\u2013115.e102. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2013.02.008","journal-title":"Am J Ophthalmol"},{"key":"4315_CR8","doi-asserted-by":"publisher","unstructured":"Zhao XY, Xia S, Chen YX (2017) Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials. Br J Ophthalmol. \n                    https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311344","DOI":"10.1136\/bjophthalmol-2017-311344"},{"key":"4315_CR9","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.ophtha.2014.03.026","volume":"121","author":"X Li","year":"2014","unstructured":"Li X, Xu G, Wang Y, Xu X, Liu X, Tang S, Zhang F, Zhang J, Tang L, Wu Q, Luo D, Ke X (2014) Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study. Ophthalmology 121:1740\u20131747. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2014.03.026","journal-title":"Ophthalmology"},{"key":"4315_CR10","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1080\/02713683.2017.1285943","volume":"42","author":"F Li","year":"2017","unstructured":"Li F, Sun M, Guo J, Ma A, Zhao B (2017) Comparison of conbercept with ranibizumab for the treatment of macular edema secondary to branch retinal vein occlusion. Curr Eye Res 42:1174\u20131178. \n                    https:\/\/doi.org\/10.1080\/02713683.2017.1285943","journal-title":"Curr Eye Res"},{"key":"4315_CR11","doi-asserted-by":"publisher","unstructured":"Li F, Zhang L, Wang Y, Xu W, Jiao W, Ma A, Zhao B (2017) One-year outcome of Conbercept therapy for diabetic macular edema. Curr Eye Res 1\u20136. \n                    https:\/\/doi.org\/10.1080\/02713683.2017.1379542","DOI":"10.1080\/02713683.2017.1379542"},{"key":"4315_CR12","doi-asserted-by":"publisher","unstructured":"Yang X, Xu J (2016) A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy 2016:2473234. \n                    https:\/\/doi.org\/10.1155\/2016\/2473234","DOI":"10.1155\/2016\/2473234"},{"key":"4315_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/bjo.2007.127142","volume":"92","author":"JF Arevalo","year":"2008","unstructured":"Arevalo JF, Maia M, Flynn H, Saravia M, Avery RL, Wu L, Farah ME, Pieramici DJ, Berrocal MH, Sanchez JG (2008) Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 92:213\u2013216","journal-title":"Br J Ophthalmol"},{"key":"4315_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.17554\/j.issn.2409-5680.2016.02.48","volume":"2","author":"Z Hu","year":"2016","unstructured":"Hu Z, Liu Q, Paulus YM (2016) New Frontiers in retinal imaging. Int Ophthalmic Res 2:148\u2013158","journal-title":"Int Ophthalmic Res"},{"key":"4315_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10792-012-9541-5","volume":"32","author":"A Gupta","year":"2012","unstructured":"Gupta A, Bansal R, Gupta V, Dogra MR (2012) Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab. Int Ophthalmol 32:135\u2013144. \n                    https:\/\/doi.org\/10.1007\/s10792-012-9541-5","journal-title":"Int Ophthalmol"},{"key":"4315_CR16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/IAE.0b013e3181bf5ff0","volume":"30","author":"H Erdol","year":"2010","unstructured":"Erdol H, Turk A, Akyol N, Imamoglu HI (2010) The results of intravitreal bevacizumab injections for persistent neovascularizations in proliferative diabetic retinopathy after photocoagulation therapy. Retina 30:570\u2013577. \n                    https:\/\/doi.org\/10.1097\/IAE.0b013e3181bf5ff0","journal-title":"Retina"},{"key":"4315_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000314721","volume":"45","author":"MA Abdelhakim","year":"2011","unstructured":"Abdelhakim MA, Macky TA, Mansour KA, Mortada HA (2011) Bevacizumab (Avastin) as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series. Ophthalmic Res 45:23\u201330. \n                    https:\/\/doi.org\/10.1159\/000314721","journal-title":"Ophthalmic Res"},{"key":"4315_CR18","doi-asserted-by":"publisher","unstructured":"Hu Z, Ding Y, Zheng X, Yuan S, Li J, Xie P, Liu Q (2018) Thin rigid contact Lens used in vitreous-retinal surgery for corneal protection: a randomized controlled trial. Eye Contact Lens. \n                    https:\/\/doi.org\/10.1097\/ICL.0000000000000491","DOI":"10.1097\/ICL.0000000000000491"},{"key":"4315_CR19","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1364\/OE.20.004710","volume":"20","author":"Y Jia","year":"2012","unstructured":"Jia Y, Tan O, Tokayer J, Potsaid B, Wang Y, Liu JJ, Kraus MF, Subhash H, Fujimoto JG, Hornegger J (2012) Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express 20:4710\u20134725. \n                    https:\/\/doi.org\/10.1364\/OE.20.004710","journal-title":"Opt Express"},{"key":"4315_CR20","doi-asserted-by":"publisher","unstructured":"Amoroso F, Miere A, Semoun O, Jung C, Capuano V, Souied EH (2017) Optical coherence tomography angiography reproducibility of lesion size measurements in neovascular age-related macular degeneration (AMD). Br J Ophthalmol bjophthalmol-2017-310569. \n                    https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310569","DOI":"10.1136\/bjophthalmol-2017-310569"},{"key":"4315_CR21","doi-asserted-by":"publisher","unstructured":"Venugopal JP, Rao HL, Weinreb RN, Pradhan ZS, Dasari S, Riyazuddin M, Puttiah NK, Rao DA, Devi S, Mansouri K (2017) Repeatability of vessel density measurements of optical coherence tomography angiography in normal and glaucoma eyes. Br J Ophthalmol bjophthalmol-2017-310637. \n                    https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310637","DOI":"10.1136\/bjophthalmol-2017-310637"},{"key":"4315_CR22","doi-asserted-by":"publisher","first-page":"076010","DOI":"10.1117\/1.JBO.21.7.076010","volume":"21","author":"SS Gao","year":"2016","unstructured":"Gao SS, Liu L, Bailey ST, Flaxel CJ, Huang D, Li D, Jia Y (2016) Quantification of choroidal neovascularization vessel length using optical coherence tomography angiography. J Biomed Opt 21:076010\u2013076010. \n                    https:\/\/doi.org\/10.1117\/1.JBO.21.7.076010","journal-title":"J Biomed Opt"},{"key":"4315_CR23","doi-asserted-by":"publisher","unstructured":"Rosen RB, Andrade Romo JS, Krawitz BD, Mo S, Fawzi AA, Linderman R, Carroll J, Pinhas A, Chui TYP (2019) Earliest evidence of preclinical diabetic retinopathy revealed using OCT angiography (OCTA) perfused capillary density. Am J Ophthalmol. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2019.01.012","DOI":"10.1016\/j.ajo.2019.01.012"},{"key":"4315_CR24","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s00417-018-4122-6","volume":"256","author":"Y Kaizu","year":"2018","unstructured":"Kaizu Y, Nakao S, Sekiryu H, Wada I, Yamaguchi M, Hisatomi T, Ikeda Y, Kishimoto J, Sonoda KH (2018) Retinal flow density by optical coherence tomography angiography is useful for detection of nonperfused areas in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 256:2275\u20132282. \n                    https:\/\/doi.org\/10.1007\/s00417-018-4122-6","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4315_CR25","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1038\/s41598-017-05663-9","volume":"7","author":"Y Dodo","year":"2017","unstructured":"Dodo Y, Suzuma K, Ishihara K, Yoshitake S, Fujimoto M, Yoshitake T, Miwa Y, Murakami T (2017) Clinical relevance of reduced decorrelation signals in the diabetic inner choroid on optical coherence tomography angiography. Sci Rep 7:5227. \n                    https:\/\/doi.org\/10.1038\/s41598-017-05663-9","journal-title":"Sci Rep"},{"key":"4315_CR26","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1167\/iovs.17-23304","volume":"59","author":"AC Onishi","year":"2018","unstructured":"Onishi AC, Nesper PL, Roberts PK, Moharram GA, Chai H, Liu L, Jampol LM, Fawzi AA (2018) Importance of considering the middle capillary plexus on OCT angiography in diabetic retinopathy. Invest Ophthalmol Vis Sci 59:2167\u20132176. \n                    https:\/\/doi.org\/10.1167\/iovs.17-23304","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4315_CR27","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1167\/iovs.17-23498","volume":"59","author":"Y Lu","year":"2018","unstructured":"Lu Y, Simonett JM, Wang J, Zhang M, Hwang T, Hagag AM, Huang D, Li D, Jia Y (2018) Evaluation of automatically quantified foveal avascular zone metrics for diagnosis of diabetic retinopathy using optical coherence tomography angiography. Invest Ophthalmol Vis Sci 59:2212\u20132221. \n                    https:\/\/doi.org\/10.1167\/iovs.17-23498","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4315_CR28","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00417-018-3992-y","volume":"256","author":"O Sawada","year":"2018","unstructured":"Sawada O, Ichiyama Y, Obata S, Ito Y, Kakinoki M, Sawada T, Saishin Y, Ohji M (2018) Comparison between wide-angle OCT angiography and ultra-wide field fluorescein angiography for detecting non-perfusion areas and retinal neovascularization in eyes with diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 256:1275\u20131280. \n                    https:\/\/doi.org\/10.1007\/s00417-018-3992-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4315_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/IAE.0000000000001938","volume":"39","author":"KB Schaal","year":"2019","unstructured":"Schaal KB, Munk MR, Wyssmueller I, Berger LE, Zinkernagel MS, Wolf S (2019) Vascular abnormalities in diabetic retinopathy assessed with swept-source optical coherence tomography angiography widefield imaging. Retina 39:79\u201387. \n                    https:\/\/doi.org\/10.1097\/iae.0000000000001938","journal-title":"Retina"},{"key":"4315_CR30","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00417-016-3565-x","volume":"255","author":"A Singh","year":"2017","unstructured":"Singh A, Agarwal A, Mahajan S, Karkhur S, Singh R, Bansal R, Dogra MR, Gupta V (2017) Morphological differences between optic disc collaterals and neovascularization on optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol 255:753\u2013759. \n                    https:\/\/doi.org\/10.1007\/s00417-016-3565-x","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4315_CR31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ajo.2018.05.018","volume":"192","author":"J Pan","year":"2018","unstructured":"Pan J, Chen D, Yang X, Zou R, Zhao K, Cheng D, Huang S, Zhou T, Yang Y, Chen F (2018) Characteristics of neovascularization in early stages of proliferative diabetic retinopathy by optical coherence tomography angiography. Am J Ophthalmol 192:146\u2013156. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2018.05.018","journal-title":"Am J Ophthalmol"},{"key":"4315_CR32","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1038\/s41598-018-22363-0","volume":"8","author":"X Zhang","year":"2018","unstructured":"Zhang X, Wu C, Zhou LJ, Dai RP (2018) Observation of optic disc neovascularization using OCT angiography in proliferative diabetic retinopathy after intravitreal conbercept injections. Sci Rep 8:3972. \n                    https:\/\/doi.org\/10.1038\/s41598-018-22363-0","journal-title":"Sci Rep"},{"key":"4315_CR33","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1016\/j.ophtha.2016.07.010","volume":"123","author":"J Lee","year":"2016","unstructured":"Lee J, Moon BG, Cho AR, Yoon YH (2016) Optical coherence tomography angiography of DME and its association with anti-VEGF treatment response. Ophthalmology 123:2368\u20132375. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2016.07.010","journal-title":"Ophthalmology"},{"key":"4315_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1167\/iovs.16-20579","volume":"58","author":"K Ghasemi Falavarjani","year":"2017","unstructured":"Ghasemi Falavarjani K, Iafe NA, Hubschman JP, Tsui I, Sadda SR, Sarraf D (2017) Optical coherence tomography angiography analysis of the foveal avascular zone and macular vessel density after anti-VEGF therapy in eyes with diabetic macular edema and retinal vein occlusion. Invest Ophthalmol Vis Sci 58:30\u201334. \n                    https:\/\/doi.org\/10.1167\/iovs.16-20579","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4315_CR35","doi-asserted-by":"publisher","unstructured":"Rizzo S, Genovesi-Ebert F, Di Bartolo E, Vento A, Miniaci S, Williams G (2008) Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR). Graefes Arch Clin Exp Ophthalmol 246:837\u2013842. \n                    https:\/\/doi.org\/10.1007\/s00417-008-0774-y","DOI":"10.1007\/s00417-008-0774-y"},{"key":"4315_CR36","doi-asserted-by":"publisher","unstructured":"Kohno R-I, Hata Y, Mochizuki Y, Arita R, Kawahara S, Kita T, Miyazaki M, Hisatomi T, Ikeda Y, Aiello LP (2010) Histopathology of neovascular tissue from eyes with proliferative diabetic retinopathy after intravitreal bevacizumab injection. Am J Ophthalmol 150:223\u2013229. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2010.03.016","DOI":"10.1016\/j.ajo.2010.03.016"},{"key":"4315_CR37","doi-asserted-by":"publisher","unstructured":"Manabe A, Shimada H, Hattori T, Nakashizuka H, Yuzawa M (2015) Randomized controlled study of intravitreal bevacizumab 0.16 mg injected one day before surgery for proliferative diabetic retinopathy. Retina (Philadelphia, Pa) 35:1800\u20131807. \n                    https:\/\/doi.org\/10.1097\/iae.0000000000000577","DOI":"10.1097\/iae.0000000000000577"},{"key":"4315_CR38","doi-asserted-by":"publisher","unstructured":"Di Lauro R, De Ruggiero P, Di Lauro R, Di Lauro MT, Romano MR (2010) Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 248:785\u2013791. \n                    https:\/\/doi.org\/10.1007\/s00417-010-1303-3","DOI":"10.1007\/s00417-010-1303-3"},{"key":"4315_CR39","doi-asserted-by":"publisher","unstructured":"El-Sabagh HA, Abdelghaffar W, Labib AM, Mateo C, Hashem TM, Al-Tamimi DM, Selim AA (2011) Preoperative intravitreal bevacizumab use as an adjuvant to diabetic vitrectomy: histopathologic findings and clinical implications. Ophthalmology 118:636\u2013641. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2010.08.038","DOI":"10.1016\/j.ophtha.2010.08.038"},{"key":"4315_CR40","doi-asserted-by":"publisher","unstructured":"Da R Lucena D, Ribeiro JA, Costa RA, Barbosa JC, Scott IU, de Figueiredo-Pontes LL, Jorge R (2009) Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study). Br J Ophthalmol 93:688\u2013691. \n                    https:\/\/doi.org\/10.1136\/bjo.2008.151233","DOI":"10.1136\/bjo.2008.151233"},{"key":"4315_CR41","doi-asserted-by":"publisher","unstructured":"Castillo J, Aleman I, Rush SW, Rush RB (2017) Preoperative bevacizumab administration in proliferative diabetic retinopathy patients undergoing vitrectomy: a randomized and controlled trial comparing interval variation. Am J Ophthalmol 183:1\u201310. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2017.08.013","DOI":"10.1016\/j.ajo.2017.08.013"},{"key":"4315_CR42","doi-asserted-by":"publisher","unstructured":"Farahvash M-S, Majidi AR, Roohipoor R, Ghassemi F (2011) Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage. Retina (Philadelphia, Pa) 31:1254\u20131260. \n                    https:\/\/doi.org\/10.1097\/IAE.0b013e31820a68e5","DOI":"10.1097\/IAE.0b013e31820a68e5"},{"key":"4315_CR43","doi-asserted-by":"publisher","unstructured":"Spaide RF, Fujimoto JG, Waheed NK (2015) Image artifacts in optical coherence tomography angiography. Retina (Philadelphia, Pa) 35:2163\u20132180. \n                    https:\/\/doi.org\/10.1097\/IAE.0000000000000765","DOI":"10.1097\/IAE.0000000000000765"},{"key":"4315_CR44","doi-asserted-by":"publisher","unstructured":"Hirano T, Kakihara S, Toriyama Y, Nittala MG, Murata T, Sadda S (2017) Wide-field en face swept-source optical coherence tomography angiography using extended field imaging in diabetic retinopathy. Br J Ophthalmol. \n                    https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311358","DOI":"10.1136\/bjophthalmol-2017-311358"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04315-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04315-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04315-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T23:14:35Z","timestamp":1588374875000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04315-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4315"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04315-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,3]]},"assertion":[{"value":"17 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.Clinical Trial Registration:  Unique identifier: ChiCTR-IPR-17014160.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}